High-Purity Rimegepant Intermediate: Synthesis and Application in Migraine Treatment
Discover a critical building block for advanced migraine therapeutics, ensuring quality and efficacy.
Get a Quote & SampleProduct Core Value
![(5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5h-Cyclohepta[B]Pyridin-9-Ol 2HCl](https://www.nbinno.com/2025/webimg/gemini_688ba5efc5864_1753982447.png)
(5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5h-Cyclohepta[B]Pyridin-9-Ol 2HCl
This high-purity chemical compound serves as a vital intermediate in the synthesis of Rimegepant, a groundbreaking medication for managing migraine conditions. Its precise molecular structure, C16H17ClF2N2O, and established CAS Number 1373116-07-4 underscore its significance in pharmaceutical manufacturing. Sourcing this Rimegepant intermediate is crucial for companies engaged in API synthesis and the development of novel treatments for neurological disorders.
- Leveraging the Rimegepant intermediate CAS 1373116-07-4 synthesis pathways allows for efficient production of the final active pharmaceutical ingredient.
- Pharmaceutical API synthesis relies on intermediates like this to ensure the quality and purity of the end-product.
- Understanding the chemical synthesis of C16H17ClF2N2O is key for optimizing production processes and achieving high yields.
- Researchers and manufacturers can buy Rimegepant intermediate dihydrochloride for laboratory and commercial applications in migraine drug development.
Key Advantages
Guaranteed Purity for Efficacy
Ensuring the highest purity of the Rimegepant intermediate is paramount for the safety and effectiveness of the final migraine medication.
Streamlined Synthesis Pathways
The availability of reliable buy Rimegepant intermediate dihydrochloride facilitates the optimization of complex synthesis processes in pharmaceutical manufacturing.
Essential for Migraine Drug Development
This compound is a cornerstone in the pharmaceutical API synthesis for novel treatments targeting severe headache conditions.
Key Applications
Migraine Therapeutic Synthesis
This intermediate is a fundamental component in the production of Rimegepant, a drug used to treat acute migraine attacks and aid in migraine prevention.
Pharmaceutical Research & Development
Its availability supports ongoing research into new formulations and potential therapeutic uses for Rimegepant and related compounds.
Custom Synthesis Projects
Companies requiring specific quantities or modified forms can utilize custom synthesis services leveraging the chemical synthesis of C16H17ClF2N2O.
Quality Control Standards
The well-defined nature of this Rimegepant intermediate CAS 1373116-07-4 makes it valuable for quality control testing in pharmaceutical production.